EP Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Buy |
10,930
+5,481
| +101% | +$2.44M | 0.03% | 269 |
|
|
2025
Q1 | $2.64M | Sell |
5,449
-989
| -15% | -$479K | 0.02% | 318 |
|
|
2024
Q4 | $2.59M | Buy |
6,438
+1,285
| +25% | +$517K | 0.02% | 315 |
|
|
2024
Q3 | $2.4M | Buy |
5,153
+244
| +5% | +$113K | 0.02% | 322 |
|
|
2024
Q2 | $2.3M | Buy |
4,909
+200
| +4% | +$93.7K | 0.02% | 259 |
|
|
2024
Q1 | $1.97M | Buy |
4,709
+197
| +4% | +$82.4K | 0.02% | 267 |
|
|
2023
Q4 | $1.84M | Sell |
4,512
-677
| -13% | -$275K | 0.02% | 275 |
|
|
2023
Q3 | $1.8M | Sell |
5,189
-4,102
| -44% | -$1.43M | 0.03% | 247 |
|
|
2023
Q2 | $1.86M | Buy |
+9,291
| New | +$1.86M | 0.03% | 247 |
|